As next-generation sequencing continues to advance into the clinic, how the US Food and Drug Administration will regulate diagnostic tests based on the technology remains a major question among corporate and academic test developers.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.
At Wired, a science journalist discusses her decision not to undergo BRCA testing.
The Japan Times says regulations are needed to oversee human genome-editing research.
In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.